Aphrodisiacs exist and effectively enhance sexual desire.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Aphrodisiacs exist and effectively enhance sexual desire?

Yes. Clinical trials and pharmacological reviews demonstrate that various pharmaceutical agents and targeted treatments effectively enhance sexual desire and treat disorders of sexual interest.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked 31 Jul 2026

The analysis

The claim is specific and falsifiable, passing Step 0. The retrieved literature includes multiple randomized controlled trials and pooled analyses demonstrating that specific pharmacologic agents (such as flibanserin, bremelanotide, and testosterone) reliably improve sexual desire and satisfying sexual events. While traditional herbal aphrodisiacs lack robust clinical backing, modern pharmacological treatments substantiate the existence of agents that effectively enhance sexual desire, supporting the overall claim.

Evidence for · 3

Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.

2017

Randomized clinical trials demonstrate that pharmacological treatments can significantly enhance sexual desire and satisfying sexual events in women.

Get citation

Tuiten, A., Rooij, K. v., Bloemers, J., Eisenegger, C., Honk, J. v., Kessels, R., Kingsberg, S., Derogatis, L., Leede, L. D. d., Gerritsen, J., Koppeschaar, H., Olivier, B., Everaerd, W., Frijlink, H., Höhle, D., Lange, R. d., Böcker, K., & Pfaus, J. (2017). Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.. doi.org. https://doi.org/10.1016/j.jsxm.2017.11.226

See more details

More for · 2

Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials

2019

Pooled analyses of clinical trials indicate that flibanserin effectively improves sexual desire and reduces distress associated with hypoactive sexual desire disorder.

Get citation

Simon, J., Thorp, J., & Millheiser, L. (2019). Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials. doi.org. https://doi.org/10.1089/jwh.2018.7516

(396) Comparative Analysis of Flibanserin, Bremelanotide, and Testosterone Therapy for Female Sexual Desire: Mechanism, Efficacy, and Clinical Considerations

2025

Clinical reviews show that approved medical treatments like flibanserin, bremelanotide, and off-label testosterone effectively improve sexual desire and frequency of satisfying events.

Get citation

Vereecken, S., Achua, J., Delgado, J., & Casperson, K. (2025). (396) Comparative Analysis of Flibanserin, Bremelanotide, and Testosterone Therapy for Female Sexual Desire: Mechanism, Efficacy, and Clinical Considerations. doi.org. https://doi.org/10.1093/jsxmed/qdaf320.390

Related receipts

Is it true that Ashwagandha supplementation increases sexual desire in adults? PARTIAL LEAN related question, same topic
Is it true that hypothyroidism lowers sexual desire in men and women? SUPPORTED related question, same topic
Is it true that hormone replacement therapy increases sexual desire in postmenopausal women? PARTIAL LEAN related question, same topic

What does the evidence say?

Receipt History

first checked31 Jul 2026

judged → SUPPORTED · 8531 Jul 2026

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work